Could a diabetes drug and supplements boost chemo for pancreatic cancer?
NCT ID NCT02336087
First seen Feb 04, 2026 · Last updated Jun 13, 2026 · Updated 21 times
Summary
This early-phase trial tests the safety and feasibility of adding the diabetes drug metformin and a specific dietary supplement blend to standard chemotherapy (gemcitabine and Abraxane) for people with pancreatic cancer that cannot be removed by surgery. The study involves 21 participants and aims to see if this combination is tolerable and can slow cancer growth. It is not a cure, but an effort to improve disease control.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC ADENOCARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
City of Hope Medical Center
Duarte, California, 91010, United States
-
City of Hope Rancho Cucamonga
Rancho Cucamonga, California, 91730, United States
-
City of Hope South Pasadena
South Pasadena, California, 91030, United States
-
City of Hope West Covina
West Covina, California, 91790, United States
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.